These parameters obtained by ROC curve analysis showed that the serum levels of IFN-α and IL-33 may be useful as diagnostic biomarkers for type 1 AIP/IgG4-RD (in addition to the well-established serum concentration of IgG4). The gene discussed is IFNA1; the disease is immunoglobulin G4-related sclerosing disease.